These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38369542)

  • 1. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
    Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
    J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer-associated T cell receptor repertoire abnormalities are linked to gut microbiome shifts and somatic cell mutations.
    Cao Y; Wang J; Hou W; Ding Y; Zhu Y; Zheng J; Huang Q; Cao Z; Xie R; Wei Q; Qin H
    Gut Microbes; 2023 Dec; 15(2):2263934. PubMed ID: 37795995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
    Avuthu N; Guda C
    Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization.
    Xiang Y; Zhang C; Wang J; Cheng Y; Wang L; Tong Y; Yan D
    J Transl Med; 2023 Aug; 21(1):535. PubMed ID: 37563724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
    Kong C; Liang L; Liu G; Du L; Yang Y; Liu J; Shi D; Li X; Ma Y
    Gut; 2023 Jun; 72(6):1129-1142. PubMed ID: 35953094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
    Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
    Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of intestinal microbiota and host gene expression in colorectal cancer patients.
    Chen Y; Si H; Bao B; Li S; Teng D; Yan Y; Hu S; Xu Y; Du X
    J Med Microbiol; 2022 Sep; 71(9):. PubMed ID: 36136380
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
    Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
    Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
    Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer and gut microbiota studies in China.
    Wang Z; Dan W; Zhang N; Fang J; Yang Y
    Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer microbiome programs DNA methylation of host cells by affecting methyl donor metabolism.
    Liu Z; Zhang Q; Zhang H; Yi Z; Ma H; Wang X; Wang J; Liu Y; Zheng Y; Fang W; Huang P; Liu X
    Genome Med; 2024 Jun; 16(1):77. PubMed ID: 38840170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omic profiling reveals associations between the gut mucosal microbiome, the metabolome, and host DNA methylation associated gene expression in patients with colorectal cancer.
    Wang Q; Ye J; Fang D; Lv L; Wu W; Shi D; Li Y; Yang L; Bian X; Wu J; Jiang X; Wang K; Wang Q; Hodson MP; Thibaut LM; Ho JWK; Giannoulatou E; Li L
    BMC Microbiol; 2020 Apr; 20(Suppl 1):83. PubMed ID: 32321427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model.
    Huang Z; Huang X; Huang Y; Liang K; Chen L; Zhong C; Chen Y; Chen C; Wang Z; He F; Qin M; Long C; Tang B; Huang Y; Wu Y; Mo X; Weizhong T; Liu J
    Microbiol Spectr; 2024 May; 12(5):e0272023. PubMed ID: 38572984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
    Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
    World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers.
    Li J; Guo Y; Liu J; Guo F; Du L; Yang Y; Li X; Ma Y
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37597851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens.
    Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
    mSphere; 2023 Apr; 8(2):e0062622. PubMed ID: 36847529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
    Zhang Q; Zhao H; Wu D; Cao D; Ma W
    BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
    Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer.
    Zhang H; Jin K; Xiong K; Jing W; Pang Z; Feng M; Cheng X
    Cancer Med; 2023 Jul; 12(14):15720-15735. PubMed ID: 37260140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.